Annex VI to Regulation (EU) No 1178/2011 is amended as follows:
In ARA.GEN.305, the following point (ca) is inserted:
‘(ca) Notwithstanding (c), for organisations only providing training towards the LAPL, PPL, SPL or BPL and associated ratings and certificates, an oversight planning cycle not exceeding 48 months shall be applied. The oversight planning cycle shall be reduced if there is evidence that the safety performance of the organisation holder has decreased.
The oversight planning cycle may be extended to a maximum of 72 months, if the competent authority has established that, during the previous 48 months:
the organisation has demonstrated an effective identification of aviation safety hazards and management of associated risks, as demonstrated by the results of the annual review in accordance with ORA.GEN.200(c);
the organisation has continuously maintained control over all changes in accordance with ORA.GEN.130 as demonstrated by the results of the annual review in accordance with ORA.GEN.200(c);
no level 1 findings have been issued; and
all corrective actions have been implemented within the time period accepted or extended by the competent authority as defined in ARA.GEN.350(d)(2).’
In ARA.FCL.200, the following point (d) is added:
‘(d) Endorsement of licence by instructors. Before specifically authorising certain instructors to revalidate a single-engine piston or TMG class rating, the competent authority shall develop appropriate procedures.’
The following point ARA.MED.330 is added:
When new medical technology, medication or procedures are identified that may justify a fit assessment of applicants otherwise not in compliance with the requirements, research may be carried out to gather evidence on the safe exercise of the privileges of the licence.
In order to undertake research, a competent authority, in cooperation with at least one other competent authority, may develop and evaluate a medical assessment protocol based on which these competent authorities may issue a defined number of pilot medical certificates with appropriate limitations.
AeMCs and AMEs may only issue medical certificates on the basis of a research protocol if instructed to do so by the competent authority.
The protocol shall be agreed between the competent authorities concerned and shall include as a minimum:
a risk assessment;
a literature review and evaluation to provide evidence that issuing a medical certificate based on the research protocol would not jeopardise the safe exercise of the privileges of the licence;
detailed selection criteria for pilots to be admitted to the protocol;
the limitations that will be endorsed on the medical certificate;
the monitoring procedures to be implemented by the competent authorities concerned;
the determination of end points for terminating the protocol.
The protocol shall be compliant with relevant ethical principles.
The exercise of licence privileges by licence holders with a medical certificate issued on the basis of the protocol shall be restricted to flights in aircraft registered in the Member States involved in the research protocol. This restriction shall be indicated on the medical certificate.
The participating competent authorities shall:
provide the Agency with:
the research protocol before implementation;
the details and qualifications of the nominated focal point of each participating competent authority;
documented reports of regular evaluations of its effectiveness;
provide the AeMCs and AMEs within their jurisdiction with details of the protocol before implementation for their information.’
Appendix I is replaced by the following:
In Appendix II, Item 9 of the instructions relating to the Standard EASA format for cabin crew attestations is replaced by the following:
‘Item 9If the competent authority is the issuing body, the term “competent authority” and official seal, stamp or logo shall be entered. In this case only, the competent authority may determine if its official seal, stamp or logo shall also be entered under Item 8.’